Brazil vs Fiji: Treatment success rate for patients treated for MDR-TB
Brazil
60.0%
in 2022
Fiji
60.0%
in 2022
Brazil rank
120th
Fiji rank
120th
Treatment success rate for patients treated for MDR-TB over time
- Brazil
- Fiji
How they compare
Brazil currently reports 60.0% against 60.0% in Fiji, a difference of 0.0%.
Across all 6 years both countries report, Fiji has been ahead every year.
Brazil ranks 120th and Fiji ranks 120th of 163 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 56.2% | 100.0% | 43.8% | Fiji |
| 2020s | 58.0% | 67.5% | 9.5% | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Brazil or Fiji?
- Brazil, at 60.0% against 60.0% in Fiji as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Brazil and Fiji?
- 0.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Fiji?
- 6 years are reported by both, from 2014 to 2022.
- How do Brazil and Fiji rank globally for treatment success rate for patients treated for mdr-tb?
- Brazil ranks 120th and Fiji ranks 120th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.